PMX 205
3-Phenoxybenzaldehyde
C1s-IN-1
N-((Allyloxy)carbonyl)-N-methyl-L-alanine
Pexelizumab
Crovalimab
Pozelimab
Olendalizumab
Vilobelimab
Gavilimomab
Gefurulimab
Avdoralimab
Vesencumab
Ravulizumab
Lampalizumab
Tesidolumab
Sutimlimab
Eculizumab
Riliprubart
Empasiprubart